Related Experiment Video
Updated: Jul 8, 2026
06:16
Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model
Published on: April 19, 2024
In vitro simulation of extremely activated thrombolysis
1Department of Clinical Chemistry, University Hospital, Marburg, Germany. thstief@med.uni
Summary
Rapidly dissolving blood clots with activated fibrinolysis is crucial for treating massive pulmonary embolism. This study shows extremely activated fibrinolysis can effectively and quickly eliminate thrombi, potentially offering a safer clinical option.
Area of Science:
- Biochemistry
- Hematology
- Cardiovascular Medicine
Background:
- Massive pulmonary embolism necessitates rapid thrombus elimination.
- Existing thrombolytic therapies carry significant risks, such as intracranial hemorrhage.
Purpose of the Study:
- To investigate the efficacy of extremely activated plasmatic fibrinolysis in rapidly lysing thrombi.
- To compare the thrombolytic potential of urokinase and tissue-type plasminogen activator.
- To assess the clinical feasibility of accelerated fibrinolysis for massive thrombi.
Main Methods:
- A microtiter plate clot lysis assay was employed.
- Plasma clots were incubated with urokinase or tissue-type plasminogen activator.
- Clot lysis time and effective doses were quantified.
Main Results:
- Fifty percent clot lysis occurred within 4 minutes using high concentrations of urokinase or tissue-type plasminogen activator.
- Effective dose 50% for 5-minute lysis was determined for both agents.
- Plasminogen addition enhanced thrombolysis under specific conditions.
Conclusions:
- Extremely activated plasmatic fibrinolysis demonstrates rapid and effective thrombus dissolution.
- The risk of intracranial hemorrhage may be lower than the lethality of massive pulmonary embolism.
- Accelerated fibrinolysis presents a potential clinical indication for treating massive thrombi.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.